Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy

Daniel A. Vallera, Hua Chen, Andrew R. Sicheneder, Angela Panoskaltsis-Mortari, Elizabeth P. Taras

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy'. Together they form a unique fingerprint.

Medicine & Life Sciences